Navigation Links
Hormones and growth: The control of body size and developmental growth rate in fruit flies

A pair of research papers published this week report findings that increase our understanding of how an organism's body size is determined and how the speed of its development is controlled. In particular, the work sheds light on the molecular and cellular pathways that act to convey information about a growing organism's size, as well as on pathways that use that information to correctly time critical transitional events during development.

The two studies are reported in Current Biology online on September 22 by Dr. Philip E. Caldwell and colleagues of Rice University and Dr. Christen Mirth and colleagues of the University of Washington.

Previous work had shown that there is a close linkage between the final body size of an organism and the length of its developmental stages: Elephants are larger and develop more slowly than mice. However, the mechanisms by which body size and developmental rate are controlled remain incompletely understood.

Both studies examine the control of larval development in the fruit fly Drosophila. Fruit flies undergo three successive larval stages and molts before undergoing metaphorphosis and emerging as adult flies. In insects, it was previously found that the release of the hormone ecdysone from an endocrine organ called the prothoracic gland triggers larval molting and, ultimately, metamorphosis. Thus, researchers have speculated that the timing of ecdysone release is critical in determining both the final body size and developmental rate of an insect.

In their new work, Philip Caldwell, Magdalena Walkiewicz, and Michael Stern manipulated the timing and amount of ecdysone release during development of the fruit fly. They induced precocious ecdysone release by specifically expressing an activated form of the signaling molecule Ras in the endocrine prothoracic gland. This precocious ecdysone release caused flies to develop more rapidly and exhibit a much smaller body size than normal. In contrast, inhibit ing Ras in the prothoracic gland prevented ecdysone release and delayed development, creating flies that are much larger than normal. On the basis of their findings, the investigators conclude that Ras activity in the prothoracic gland regulates body size and developmental rate by regulating ecdysone release.

In the second study, Christen Mirth, James W. Truman, and Lynn M. Riddiford address how developing flies sense that they have reached the proper size to initiate a new phase of development. Their new findings show that the prothoracic gland'the organ that releases ecdysone'itself acts as a size-sensing tissue. The researchers found that by manipulating the growth of specific cells within the gland, they were able to control the timing of metamorphosis and the body size of adult flies. They showed that artificial enlargement of the prothoracic gland appeared to cause an overestimation of the larval flies' overall body size, prompting the initiation of metamorphosis before the flies surpassed the minimal viable weight necessary to survive pupation. On the basis of their findings, the authors propose that under normal conditions, growth of prothoracic gland during development helps larval flies determine when a critical body weight has been reached and when metamorphosis should be initiated.


'"/>

Source:Cell Press


Related biology news :

1. Ancient olfaction protein is shared by many bugs, offering new pest control target
2. Gene variations explain drug dose required to control seizures
3. U-M scientists find genes that control growth of common skin cancer
4. Scientists discuss improved biopesticides for locust control in West Africa
5. Insight into natural cholesterol control suggests novel cholesterol-lowering therapy
6. To control germs, scientists deploy tiny agents provocateurs
7. Cooperation is key—a new way of looking at MicroRNA and how it controls gene expression
8. Master gene controls healing of skin in fruit flies and mammals
9. Remote control flies? Fly behavior controlled by laser light
10. Internet viruses help ecologists control invasive species
11. DNA constraints control structure of attached macromolecules
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/15/2016)... Germany , December 15, 2016 ... announced an agreement with NuData Security, an award-winning ... partnership will enable clients to focus on good customer experience, ... protection regulation. ... In order to provide a one-stop fraud prevention suite, ...
(Date:12/15/2016)...  There is much more to innovative access systems ... Continental will demonstrate the intelligence of today,s solutions at ... Through the combination of the keyless entry and start ... the international technology company is opening up new possibilities ... "The integration of biometric elements brings our expertise ...
(Date:12/8/2016)... , Dec. 8, 2016  Singulex, Inc., the leader ... technology, entered into a license and supply agreement with ... The agreement provides Singulex access to Thermo Scientific BRAHMS ... is used to diagnose systemic bacterial infection ... to aid in assessing the risk of ...
Breaking Biology News(10 mins):
(Date:1/21/2017)... ... January 20, 2017 , ... ... to the healthcare industry ( http://www.gandlscientific.com ), has announced the opening of new ... clinical and scientific consultants and contractors. This is the latest step in G&L’s ...
(Date:1/21/2017)... ... January 21, 2017 , ... Nova Oculus Partners has ... pioneering medical device for the treatment of Age-Related Macular Degeneration. , The company’s ... global regulatory consultancy that helps companies like ours secure government approvals for their ...
(Date:1/21/2017)... 20, 2017 Bioptix, Inc. (Nasdaq: ... that on January 14, 2017 the Board of Directors ... Company will terminate certain employees associated with the September ... Company commenced terminations on January 16, 2017 and terminations ... Company may pay severance benefits in certain circumstances of ...
(Date:1/21/2017)... Jan. 21, 2017   Boston Biomedical , an ... to target cancer stemness pathways, today presented data from ... at the 2017 American Society of Clinical Oncology (ASCO) ... . In a Phase Ib/II study ... to inhibit cancer stemness pathways by targeting STAT3 – ...
Breaking Biology Technology: